Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in the development of targeted therapies for solid tumors due to its ability to modulate signaling pathways. Also employed in structure-activity relationship (SAR) studies to optimize potency and selectivity in drug candidates. Its structural features support binding to ATP pockets in kinases, making it valuable in designing small-molecule inhibitors. Investigated for use in combination therapies to overcome drug resistance in oncology.